Dystrogen Therapeutics
0 followers
‌
Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases. The company is currently testing DEC therapy for Duchenne Muscular Dystrophy.
Industries
Headquarters
Employees
Links
Org chart
Kris Siemionow
Co-Founder & CEO
Kris Siemionow
Collapse
Maria Siemionow
Founder & CSO
Michał Żółtowski
Member Of The Supervisory Board
Similar companies
GRAIL
27 followers
Cytokinetics
11 followers
Emergent BioSolutions
4 followers
BridgeBio
2 followers
Neogene Therapeutics
2 followers
Thermo Fisher Scientific
147 followers
Gilead Sciences
121 followers
Biogen
108 followers
Regeneron
89 followers
Agilent Technologies
61 followers
Vertex Pharmaceuticals
50 followers
Discover companies